1,129
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Exploitation of microbial forensics and nanotechnology for the monitoring of emerging pathogens

Pages 504-521 | Received 28 May 2017, Accepted 14 Feb 2018, Published online: 07 Mar 2018

References

  • Alivisatos AP, Johnsson KP, Peng X, Wilson TE, Loweth CJ, Bruchez MP, Schultz PG. 1996. Organization of 'nanocrystal molecules' using DNA. Nature. 382:609–611.
  • Allard MW. 2016. The future of whole-genome sequencing for public health and the clinic. J Clin Microbiol. 54:1946–1948.
  • Arita I, Nakane M, Kojima K, Yoshihara N, Nakano T, El-Gohary A. 2004. Role of a sentinel surveillance system in the context of global surveillance of infectious diseases. Lancet Infect Dis. 4:171–177.
  • Ashraf S, Pelaz B, del Pino P, Carril M, Escudero A, Parak WJ, Soliman MG, Zhang Q, Carrion CC. 2016. Gold-based nanomaterials for applications in nanomedicine. Top Curr Chem. 370:169–202.
  • Babcock IC, Nouhan PP, Rice K. 2003. Syndromic analysis of computerized emergency department patients' chief complaints: an opportunity for bioterrorism and influenza surveillance. Ann Emerg Med. 41:447–452.
  • Basu M, Seggerson S, Henshaw J, Jiang J, del A Cordona R, Lefave C, Boyle PJ, Miller A, Pugia M, Basu S. 2004. Nano-biosensor development for bacterial detection during human kidney infection: use of glycoconjugate-specific antibody-bound gold NanoWire arrays (GNWA). Glycoconj J. 21:487–496.
  • Binnewies TT, Motro Y, Hallin PF, Lund O, Dunn D, La T, Hampson DJ, Bellgard M, Wassenaar TM, Ussery DW. 2006. Ten years of bacterial genome sequencing: comparative-genomics-based discoveries. Funct Integr Genomics. 6:165–185.
  • Biteen JS, Blainey PC, Cardon ZG, Chun M, Church GM, Dorrestein PC, Fraser SE, Gilbert JA, Jansson JK, Knight R, et al. 2016. Tools for the microbiome: nano and beyond. ACS Nano. 10:6–37.
  • Blattner FR, Plunkett G, III, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew JF, et al. 1997. The complete genome sequence of Escherichia coli K-12. Science. 277:1453–1462.
  • Bossi P, Tegnell A, Baka A, Loock FV, Hendriks J, Werner A, Maidhof H, Gouvras G. 2004. Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis. Euro Surveill. 9:E17–E18.
  • Breeze RG; Budowle B, Schutzer SE, editors. Microbial Forensics. (2005). ISBN: 0-12-088483-6. Elsevier Academic Press.
  • Budowle B, Schutzer SE, Einseln A, Kelley LC, Walsh AC, Smith JA, Marrone BL, Robertson J, Campos J. 2003. Public health. Building microbial forensics as a response to bioterrorism. Science. 301:1852–1853.
  • Budowlea B, Johnson MD, Fraserc CM, Leightond TJ, Murche RS, Chakraborty R. 2005. Genetic analysis and attribution of microbial forensics evidence. Crit Rev Microbiol. 31:233–254.
  • Burke DS. 1998. Evolvability of emerging viruses. In: A.M Nelson C.R. Horsburgh editors. Pathology of emerging infections. Washington: American Society for Microbiology; 1–12.
  • Cangelosi GA, Meschke JS. 2014. Dead or alive: molecular assessment of microbial viability. Appl Environ Microbiol. 80:5884–5891.
  • Carneiro HA, Mylonakis E. 2009. Google trends: a web-based tool for real-time surveillance of disease outbreaks. Clin Infect Dis. 49:1557–1564.
  • Casadevall A, Relman DA. 2010. Microbial threat lists: obstacles in the quest for biosecurity? Nat Rev Microbiol. 8:149–154.
  • CDC. 2000. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm Rep. 49:1.
  • Chen H, Weiss J, Shahidi F. 2006. Nanotechnology in nutraceuticals and functional foods. Food Technol. 60:30.
  • Choi JW, Oh BK. 2008. Optical detection of pathogens using protein chip. In: Kim YJ, Platt U, editors. Advanced environmental monitoring. Seoul, Korea: Springer. p. 348–362.
  • Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM. 1997. Biological warfare. A historical perspective. JAMA. 278:412–417.
  • Cleaveland S, Laurenson MK, Taylor LH. 2001. Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence. Philos Trans R Soc Lond B Biol Sci. 356:991–999.
  • Cooper MA. 2002. Optical biosensors in drug discovery. Nat Rev Drug Discov. 1:515–528.
  • Dance DAB. 2005. Melioidosis and glanders as possible biological weapons. In: I.W. Fong, A. Kenneth, editors. Bioterrorism and infectious agents: a new dilemma for the 21st century. New York: Springer. 99–145.
  • Danks C, Barker I. 2000. On-site detection of plant pathogens using lateral-flow devices. EPPO Bull. Bulletin OEPP/EPPO Bulletin. 30:421–426.
  • Darling AE, Jospin G, Lowe E, Matsen FA, Bik HM, Eisen JA. 2014. PhyloSift: phylogenetic analysis of genomes and metagenomes. Peer J. 2:e243.
  • Davies TJT, Pedersen AB. 2008. Phylogeny and geography predict pathogen community similarity in wild primates and humans. Phylog Proc R Soc B. 275:1695–1701.
  • Davydova A, Vorobjeva M, Pyshnyi D, Altman S, Vlassov V, Venyaminova A. 2016. Aptamers against pathogenic microorganisms. Crit Rev Microbiol. 42:847–865.
  • Derbes VJ. 1996. De Mussis and the great plague of 1348. A forgotten episode of bacteriological warfare. JAMA. 196:59–62.
  • Dewey FM, Macdonald MM, Philips SI, Priestley RA. 1990. Development of monoclonal-antibody-ELISA and -DIP-STICK immunoassays for Penicillium islandicum in rice grains. J Gen Microbiol. 136:753–760.
  • Diba FS, Kim S, Lee HJ. 2015. Amperometric bioaffinity sensing platform for avian influenza virus proteins with aptamer modified gold nanoparticles on carbon chips. Biosens Bioelectron. 75:355–361.
  • Donaldson KA, Kramer MF, Lim DV. 2004. A rapid detection method for Vaccinia virus, the surrogate for smallpox virus. Biosens Bioelectron. 20:322–327.
  • Dong J, Olano JP, McBride JW, Walker DH. 2008. Emerging pathogens: challenges and successes of molecular diagnostics. J Mol Diagn. 10:185–197.
  • Dudak FC, Boyaci IH. 2009. Rapid and label-free bacteria detection by surface plasmon resonance (SPR) biosensors. Biotech. 4:1003–1011.
  • Engler KH, Efstratiou A, Norn D, Kozlov RS, Selga I, Glushkevich TG, Tam M, Melnikov VG, Mazurova IK, Kim VE, et al. 2002. Immunochromatographic strip test for rapid detection of diphtheria toxin: description and multicenter evaluation in areas of low and high prevalence of diphtheria. J Clin Microbiol. 40:80–83.
  • Eysenbach G. 2006. Infodemiology: tracking flu-related searches on the web for syndromic surveillance. AMIA Annu Symp Proc. 244–248.
  • Farrow B, Hong SA, Romero EC, Lai B, Coppock MB, Deyle KM, Finch AS, Stratis-Cullum DN, Agnew HD, Yang S, et al. 2013. A chemically synthesized capture agent enables the selective, sensitive, and robust electrochemical detection of anthrax protective antigen. ACS Nano. 7:9452–9460.
  • Ferguson NM, Cummings DAT, Cauchemez S, Fraser S, Riley S. 2005. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 437:209–214.
  • Fletcher J, Bender C, Budowle B, Cobb WT, Gold SE. 2006. Plant pathogen forensics: capabilities, needs, and recommendations. Microbiol Mol Biol Rev. 70:450–471.
  • Fornaciari A. 2017. Environmental microbial forensics and archaeology of past pandemics. Microbiol Spectr. 5. DOI:10.1128/microbiolspec.EMF-0011-2016.
  • Fournier PE, Dubourg G, Raoult D. 2014. Clinical detection and characterization of bacterial pathogens in the genomics era. Genome Med. 6:114.
  • Frenk J, Gomez-Dantes O. 2002. Globalisation and the challenges to health systems. BMJ. 325:95–97.
  • Friedman CP, Altman RB, Kohane IS, McCormick KA, Miller PL, et al. 2004. Training the next generation of informaticians: the impact of “BISTI” and bioinformatics–a report from the American College of Medical Informatics. J Am Med Informatics Assoc. 11:167–172.
  • Geho DH, Jones CD, Petricoin EF, Liotta LA. 2006. Nanoparticles: potential biomarker harvesters. Curr Opin Chem Biol. 10:56–61.
  • Gilbride KA, Lee DY, Beaudette LA. 2006. Molecular techniques in wastewater: Understanding microbial communities, detecting pathogens, and real-time process control. J Microbiol Methods. 66:1–20.
  • Gilchrist CA, Turner SD, Riley MF, Petri WA Jr, Hewlett EL. 2015. Whole-genome sequencing in outbreak analysis. Clin Microbiol Rev. 28:541–563.
  • Ginsberg J, Mohebbi MH, Patel RS, Brammer L, Smolinski MS, Brilliant L. 2009. Detecting influenza epidemics using search engine query data. Nature. 457:1012–1014.
  • Godoy D, Randle G, Simpson AJ, Aanensen DM, Pitt TL, Kinoshita R, Spratt BG. 2003. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J Clin Microbiol. 41:2068–2079.
  • Hahn MA, Tabb JS, Krauss TD. 2005. Detection of single bacterial pathogens with semiconductor quantum dots. Anal Chem. 77:4861–4869.
  • Handelsman J, Rondon MR, Brady SF, Clardy J, Goodman RM. 1998. Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chem Biol. 5:R245–R249.
  • Harrison JW, Ngoc Dung TT, Siddiqui F, Korbrisate S, Bukhari H, et al. 2014. Identification of possible virulence marker from Campylobacter jejuni isolates. Emerg Infect Dis. 20:1026–1029.
  • Hedberg CW, Besser JM. 2006. Commentary: cluster evaluation, PulseNet, and public health practice. Foodborne Pathog Dis. 3:32–35.
  • Heffernan R, Mostashari Das FD, Karpati A, Kulldorff M, Weiss D. 2004. Syndromic surveillance in public health practice, New York City. Emerging Infect Dis. 10:858–864.
  • Henkel JH, Aberle SW, Kundi M, Popow-Kraupp T. 1997. Improved detection of respiratory syncytial virus in nasal aspirates by seminested RT-PCR. J Med Virol. 53:366–371.
  • Heymann DL, Rodier GR. 2001. Hot spots in a wired world: WHO surveillance of emerging and re-emerging infectious diseases. Lancet Infect Dis. 1:345–353.
  • Hilleman MR. 2002. Overview: cause and prevention in biowarfare and bioterrorism. Vaccine. 20:3055–3067.
  • Ilic B, Yang Y, Craighead HG. 2004. Virus detection using nanoelectromechanical devices. Appl Phys Lett. 85:2604–2606.
  • Ivnitski D, Abdel-Hamid I, Atanasov P, Wilkins E. 1999. Biosensors for detection of pathogenic bacteria. Biosens. Bioelectron. 14:599–524.
  • Jain KK. 2005. Nanotechnology in clinical laboratory diagnostics. Clin Chim Acta. 358:37–54.
  • Jain KK. 2007. Applications of nanobiotechnology in clinical diagnostics. Clin Chem. 53:2002–2009.
  • Johnson CJ, Zhukovsky N, Cass AE, Nagy JM. 2008. Proteomics, nanotechnology and molecular diagnostics. Proteomics. 8:715–730.
  • Jung YL, Jung C, Parab H, Li T, Park HG. 2010. Direct colorimetric diagnosis of pathogen infections by utilizing thiol-labeled PCR primers and unmodified gold nanoparticles. Biosens Bioelectron. 25:1941–1946.
  • Kaittanis C, Nath S, Perez JM. 2008. Rapid nanoparticle-mediated monitoring of bacterial metabolic activity and assessment of antimicrobial susceptibility in blood with magnetic relaxation. PLoS One. 23:e3253.
  • Keddy KH, Sooka A, Parsons MB, Njanpop-Lafourcade BM, Fitchet K, Smith AM. 2013. Diagnosis of Vibrio cholerae O1 Infection in Africa. J Infect Dis. 208:23–31.
  • Kim YP, Kim HS. 2016. Nanoparticles for use in enzyme assays. Chembiochem. 17:275–282.
  • Kuiper I. 2016. Microbial forensics: next-generation sequencing as catalyst: the use of new sequencing technologies to analyze whole microbial communities could become a powerful tool for forensic and criminal investigations. EMBO Rep. 17:1085–1087.
  • Kuznetsov YG, Daijogo S, Zhou J, Semler BL, McPherson A. 2005. Atomic force microscopy analysis of icosahedral virus RNA. J Mol Biol. 347:41–52.
  • Lagier J-C, Million M, Hugon P, Armougom F, Raoult D. 2012. Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol. 2:136. DOI:10.3389/fcimb.2012.00136
  • Land M, Hauser L, Jun SR, Nookaew I, Leuze MR, Ahn TH, Karpinets T, Lund O, Kora G, Wassenaar T, et al. 2015. Insights from 20 years of bacterial genome sequencing. Funct Integr Genomics. 15:141–161.
  • Lane CR, Hobden E, Walker L, Barton VC, Inman AJ, Hughes KJD, Swan H, Colyer A, Barker I, et al. 2007. Evaluation of a rapid diagnostic field test kit for identification of Phytophthora species, including P. ramorum and P. kernoviae at the point of inspection. Plant Pathol. 56:828–835.
  • Lax S, Hampton-Marcell JT, Gibbons SM, Colares GB, Smith D, Eisen JA, Gilbert JA. 2015. Forensic analysis of the microbiome of phones and shoes. Microbiome. 3:21.
  • Layne SP, Beugelsdijk TJ. 1998. Laboratory firepower for infectious disease research. Nat Biotechnol. 16:825–829.
  • Leitenberg M. 2001. Biological weapons in the twentieth century: a review and analysis. Crit Rev Microbiol. 27:267–220.
  • Li C, Zhang P, Wang X, Liu X, Zhao Y, Sun C, Wang C, Yang R, Zhou L. 2015. Development and comparative evaluation of up-converting phosphor technology based lateral flow assay for rapid detection of Yersinia pestis, Bacillus anthracis spore and Brucella spp. Zhonghua Yu Fang Yi Xue Za Zhi. 49:3–8.
  • Longini IM Jr, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DAT, Halloran ME. 2005. Containing pandemic influenza at the source. Science. 309:1083–1087.
  • Mandl KD, Overhage JM, Wagner MM, Lober WB, Sebastiani P, Mostashari F, Pavlin JA, Gesteland PH, Treadwell T, Koski E, et al. 2004. Implementing syndromic surveillance: a practical guide informed by the early experience. J Am Med Inform Assoc. 11:141–150.
  • Mathusa EC, Yuhuan C, Elena E, Lloyd H. 2010. Non-O157 shiga toxin-producing Escherichia coli in foods. J Food Prot. 73:1721–1736.
  • McEwen SA, Wilson TM, Ashford DA, Heegaard ED, Kournikakis B. 2006. Microbial forensics for natural and intentional incidents of infectious disease involving animals. Rev - off Int Epizoot. 25:329–339.
  • MMWR 2010. Update: outbreak of cholera —Haiti. MMWR Morbidity and Mortality Weekly Report. 59:1586–1590.
  • Morelli G, Song Y, Mazzoni CJ, Eppinger M, Roumagnac P, Wagner DM, Feldkamp M, Kusecek B, Volger AJ, Li Y, et al. 2010. Phylogenetic diversity and historical patterns of pandemic spread of Yersinia pestis. Nat Genet. 42:1140–1143.
  • Morens DM, Fauci AS. 2013. Emerging Infectious Diseases: Threats to Human Health and Global Stability. PLoS Pathog. 9:e1003467.
  • Mukherjee S, Stamatis D, Bertsch J, Ovchinnikova G, Verezemska O, Isbandi M, Thomas AD, Ali R, Sharma K, Kyrpides NC, et al. 2017. Genomes OnLine Database (GOLD) v.6: data updates and feature enhancements. Nucl. Acids Res. 45:D446–D456.
  • Murch RS. 2004. Microbial forensics: building a national capacity to investigate bioterrorism. Biosec Bioterror Biodefense Strat Pract Sci. 1:117–122.
  • National Electronic Disease Surveillance System Working Group. 2001. National Electronic Disease Surveillance System (NEDSS): a standards-based approach to connect public health and clinical medicine. J Public Health Manag Pract. 7:43–50.
  • New York Times. Google uses searches to track flu’s spread. 2008. http://www.nytimes.com/2008/11/12/technology/internet/12flu.html?_rp1
  • O’Connor MJ, Buckeridge DL, Choy M, Crubezy M, Pincus Z, Musen MA. 2003. BioSTORM: a system for automated surveillance of diverse data sources. AMIA Annu Symp Proc. 1071.
  • Olano JP, Walker DH. 2011. Diagnosing emerging and reemerging infectious diseases: the pivotal role of the pathologist. Arch Pathol Lab Med. 135:83–91.
  • O’Shea MK, Ryan MAK, Hawksworth AW, Alsip BJ, Gray GC. 2005. Symptomatic respiratory syncytial virus infection in previously healthy young adults living in a crowded military environment. Clin Infect Dis. 41:311–317.
  • Overbeek R, Begley T, Butler RM, Choudhuri JV, Chuang HY, Cohoon M, et al. 2005. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res. 33:5691–5702.
  • Pace NR, Stahl DA, Lane DJ, Olsen GJ. 1985. Analyzing natural 528 microbial populations by rRNA sequences. ASM News. 51:4–12.
  • Page AL, Alberti KP, Mondonge V, Rauzier Quilici MJ, Guerin PJ. 2012. Evaluation of a rapid test for the diagnosis of cholera in the absence of a gold standard. PLoS One. 7:1–7.
  • Peng F, Wang Z, Zhang S, Wu R, Hu S, Li Z, Wang X, Bi D. 2008. Portable chemical sensors: weapons against bioterrorism. Clin Vaccine Immunol. 15:567.
  • Piarroux R, Frerichs RR. 2015. Cholera and blame in Haiti. Lancet Infect Dis. 15:1380–1381.
  • Polgreen PM, Chen Y, Pennock DM, Nelson FD, Weinstein RA. 2008. Using internet searches for influenza surveillance. Clin Infect Dis. 47:1443–1448.
  • Radwan SH, Azzazy HM. 2009. Gold nanoparticles for molecular diagnostics. Expert Rev Mol Diagn. 9:511–524.
  • Rappuoli R. 2004. From Pasteur to genomics: progress and challenges in infectious diseases. Nat Med. 10:1177–1185.
  • Reznickova A, Novotna Z, Kvitek O, Kolska Z, Svorcik V. 2015. Gold, silver and carbon nanoparticles grafted on activated polymers for biomedical applications. J Nanosci Nanotechnol. 15:10053–10073.
  • Ross SA, Srinivas PR, Clifford AJ, Lee SC, Philbert MA, Hettich RL. 2004. New technologies for nutrition research. J Nutr. 134:681–685.
  • Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. 2002. Public health assessment of potential biological terrorism agents. Emerging Infect Dis. 8:225–230.
  • Sajid M, Kawde AN, Daud M. 2015. Designs, formats and applications of lateral flow assay: a literature review. J Saudi Chem Soc. 19:689–705.
  • Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Turner P, Parkhill J, Loman NJ, Walker AW. 2014. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 12:87.
  • Schmidt TM, De Long EF, Pace NR. 1991. Analysis of a marine picoplankton community by 16S rRNA gene cloning and sequencing. J Bacteriol. 173:4371–4378.
  • Schutzer SE, Budowle B, Atlas RM. 2005. Biocrimes, microbial forensics, and the physician. PLoS Med. 2:e337.
  • Shah MA, Mutreja A, Thomson N, Baker S, Parkhill J, Dougan G, Bokhari H, Wren BW. 2014. Genomic epidemiology of Vibrio cholerae O1 associated with Floods, Pakistan, 2010. Emerging Infect Dis. 20:13–20.
  • Shim WB, Yang ZY, Kim JS, Kim JY, Kang SJ, Woo GJ, Chung YC, Eremin SA, Chung DH. 2007. Development of immunochromatography strip-test using nanocolloidal gold-antibody probe for the rapid detection of Aflatoxin B1 in grain and feed samples. J Microbiol Biotechnol. 17:1629–1637.
  • Siddiqui F, Eqani SAMAS, Studholme DJ, Champion OL, Wren BW, Titball RW, Bokhari H. 2015. Molecular detection identified a type six secretion system in Campylobacter jejuni from various sources but not from human cases. J Appl Microbiol. 118:1191–1198.
  • Sinclair R, Boone SA, Greenberg D, Keim P, Gerba CP. 2008. Persistence of category A select agents in the environment. Appl Environ Microbiol. 74:555–563.
  • Singh J, Sharma S, Nara S. 2015. Evaluation of gold nanoparticle based lateral flow assays for diagnosis of enterobacteriaceae members in food and water. Food Chem. 170:470–483.
  • Sithigorngul P, Rukpratanporn S, Pecharaburanin N, Suksawat P, Longyant S, Chaivisuthangkur P, Sithigorngul W. 2007. A simple and rapid immunochromatographic test strip for detection of pathogenic isolates of Vibrio harveyi. Microbiol Methods. 71:256–264.
  • Stephen IB, Chen BH. 2016. Nanomaterial-based sensors for detection of foodborne bacterial pathogens and toxins as well as pork adulteration in meat products. J Food Drug Anal. 24:15–28.
  • Syed MA, Bhatti AS, Li C, Bokhari H. 2011. Use of SPR biosensor for the study of proteolytic action of a serine protease enzyme. Am J Biomed Sci. 3:253–257.
  • Syed MA, Bukhari SH. 2011. Gold nanoparticle based microbial detection and identification. J Biomed Nanotechnol. 7:229–237.
  • Taniguchi N. 1974. On the basic concept of nano-technology. Proc Intl Conf Prod Eng. Tokyo, Japan, Part II: Japan Society of Precision Engineering
  • Tian ZQ, Ren B, Wu DY. 2002. Surface-enhanced raman scattering: from noble to transition metals and from rough surfaces to ordered nanostructures. J Phys Chem B. 106:9463–9483.
  • Trujillo E, Davis C, Milner J. 2006. Nutrigenomics, proteomics, metabolomics, and the practice of dietetics. J Am Diet Assoc. 106:403–413.
  • Urwin R, Maiden MC. 2003. Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol. 11:479–487.
  • van Belkum A, Tassios P, Dijkshoorn L, Haeggman S, et al. 2007. Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect. 13:1–46.
  • van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus ADME, Haagmans BL, Gorbalenya AE, Snijder EJ, et al. 2012. Genome characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 3:e00473–e00412.
  • Veigas B, Fernandes AR, Baptista PV. 2014. AuNPs for identification of molecular signatures of resistance. Front Microbiol. 5:455.
  • Veigas B, Machado D, Perdigão J, Portugal I, Couto I, Viveiros M, Baptista PV. 2010. Au-nanoprobes for detection of SNPs associated with antibiotic resistance in Mycobacterium tuberculosis. Nanotechnology. 21:415101.
  • Vorou RM, Papavassiliou VG, Tsiodras S. 2007. Emerging zoonoses and vector-borne infections affecting humans in Europe. Epidemiol Infect. 135:1231–1247.
  • Waag DM, DeShazer D. 2004. Glanders: new insights into an old dis ease. In: Lindler LE, Lebeda FJ, Korch GW, editors. Biological weapons defense: infectious diseases and counter bioterrorism. Totowa, NJ: Humana Press; 209.
  • Wagner V, Dullaart A, Bock AK, Zweck A. 2006. The emerging nanomedicine landscape. Nat Biotechnol. 24:1211–1217.
  • Watson JD, Crick FH. 1953. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 171:737–738.
  • Weiss RA. 2001. The Leeuwenhoek Lecture 2001. Animal origins of human infectious disease. Philos Trans R Soc Lond B Biol Sci. 356:957–977.
  • Wolfe ND, Dunavan CP, Diamond J. 2007. Origins of major human infectious diseases. Nature. 447:279–283.
  • Woolhouse M, Gaunt E. 2007. Ecological origins of novel human pathogens. Crit Rev Microbiol. 33:231–242.
  • Woolhouse MEJ, Haydon DT, Antia R. 2005. Emerging pathogens: the epidemiology and evolution of species jumps. Trends Ecol Evol. 20:238–244.
  • Woolhouse MEJ, Sequeria SG. 2005. Host range and emerging and reemerging pathogens. Emerging Infect Dis. 11:1842–1847.
  • Zheng MZ, Richard JL, Binder J. 2006. A review of rapid methods for the analysis of mycotoxins. Mycopathologia. 161:261–273.
  • Zheng YZ, Hyatt A, Wang LF, Eaton BT, Greenfield PF, Reid S. 1999. Quantification of recombinant core-like particles of bluetongue virus using immunosorbent electron microscopy. J Virol Methods. 80:1–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.